BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37925939)

  • 1. Jin-Fu-An decoction manipulation of macrophage polarization via β-catenin (CTNNB1) synergizes with cisplatin in lung cancer.
    Tang Y; Sun Z; Wu S; Zhang C; Zhang Y; Cao Y
    Biomed Pharmacother; 2023 Dec; 168():115828. PubMed ID: 37925939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
    Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.
    Wu ATH; Srivastava P; Yadav VK; Tzeng DTW; Iamsaard S; Su EC; Hsiao M; Liu MC
    Toxicol Appl Pharmacol; 2020 Aug; 401():115109. PubMed ID: 32544403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariside II modulates pulmonary fibrosis via PI3K/Akt/β-catenin pathway inhibition of M2 macrophage program.
    Deng L; Ouyang B; Tang W; Wang N; Yang F; Shi H; Zhang Z; Yu H; Chen M; Wei Y; Dong J
    Phytomedicine; 2024 May; 130():155687. PubMed ID: 38759312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
    Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
    Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
    Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
    J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway.
    Huang WC; Kuo KT; Wang CH; Yeh CT; Wang Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):180. PubMed ID: 31036057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Bamodu OA; Kuo KT; Wang CH; Huang WC; Wu ATH; Tsai JT; Lee KY; Yeh CT; Wang LS
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer.
    Sarode P; Zheng X; Giotopoulou GA; Weigert A; Kuenne C; Günther S; Friedrich A; Gattenlöhner S; Stiewe T; Brüne B; Grimminger F; Stathopoulos GT; Pullamsetti SS; Seeger W; Savai R
    Sci Adv; 2020 Jun; 6(23):eaaz6105. PubMed ID: 32548260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.
    Kawaguchi Y; Ohshio Y; Watanabe A; Shiratori T; Okamoto K; Ueda K; Kataoka Y; Suzuki T; Hanaoka J
    Cancer Sci; 2023 Mar; 114(3):750-763. PubMed ID: 36411518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content.
    Gunalp S; Helvaci DG; Oner A; Bursalı A; Conforte A; Güner H; Karakülah G; Szegezdi E; Sag D
    Front Immunol; 2023; 14():1209249. PubMed ID: 37809073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water extract of ginseng and astragalus regulates macrophage polarization and synergistically enhances DDP's anticancer effect.
    Chen Y; Bi L; Luo H; Jiang Y; Chen F; Wang Y; Wei G; Chen W
    J Ethnopharmacol; 2019 Mar; 232():11-20. PubMed ID: 30529424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrastigma polysaccharide reprogramming of tumor-associated macrophages via PPARγ signaling pathway to play antitumor activity in breast cancer.
    Liu X; Liu X; Mao W; Guo Y; Bai N; Jin L; Shou Q; Fu H
    J Ethnopharmacol; 2023 Oct; 314():116645. PubMed ID: 37196813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model.
    Zhang H; Almuqbil RM; Alhudaithi SS; Sunbul FS; da Rocha SRP
    Int J Pharm; 2021 Apr; 598():120350. PubMed ID: 33545279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP/STAT3 inhibited CD8
    Wang C; Shen N; Guo Q; Tan X; He S
    Cancer Med; 2023 Aug; 12(15):16295-16309. PubMed ID: 37329188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.